Live Breaking News & Updates on Angelos Stergiou

Stay updated with breaking news from Angelos stergiou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CDK9 Inhibitor SLS009 Displays Activity in Relapsed/Refractory AML

Enrollment of patients in a phase 2 study evaluating SLS009 in relapsed/refractory AML has been completed and the agent demonstrated initial efficacy. ....

Angelos Stergiou ,

SLS009 Plus Venetoclax/Azacitidine Produces Responses in R/R AML, Including ASXL1+ Disease

SLS009 plus venetoclax and azacitidine elicited responses in patients with relapsed/refractory AML, particularly in those harboring ASXL1 mutations. ....

Angelos Stergiou , Life Sciences Group , Sciences Group , Hematologic Oncology , Acute Myeloid Leukemia ,